Result of GM

Summary by AI BETAClose X

Genflow Biosciences Plc announced that all resolutions were passed at its General Meeting, with shareholders overwhelmingly approving the Director's authority to allot securities by 98.2% and disapplying statutory pre-emption rights by 97.1%. These approvals, with 224,571,419 votes for the first resolution and 222,245,570 votes for the second, grant the company significant flexibility in managing its capital structure and future fundraising activities.

Disclaimer*

UK 100

Latest directors dealings